The safeguarding of an approved medicine against competition from generic medicines, surpassing the protection granted by data exclusivity. Within this timeframe, applications for generics may be accepted and approved, but generic medicines are not permitted for market distribution.
Signal Management Process
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management